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Abstract : Transthoracic subtotal esophagectomy for esophageal cancer is a 
highly invasive procedure, associated with high mortality and morbidity rates.  
We examined the use of video-assisted thoracoscopic and laparoscopic surgery 
for esophagectomy （VATS-E）.  Further, incentive spirometry （IS） is com-
monly used in perioperative rehabilitation for esophagectomy.  We investigated 
whether pulmonary complications after VATS-E are related to changes in the 
perioperative IS volumes and whether such changes could be predictive of 
these complications.  This study included 63 patients who underwent VATS-E 
from June 2008 to December 2009.  IS volumes before and after surgery were 
recorded for all patients.  The perioperative IS volumes and clinicopathological 
factors were correlated with the incidence of postoperative pneumonia and 
atelectasis.  Nine patients （14.5%） had postoperative pneumonia, and thirteen 
（22.2%） had atelectasis.  Univariate analysis showed an increased risk of 
atelectasis in patients with diabetes and an increased risk of pneumonia in 
patients with a long operating time and for whom the lung was adhered to 
the thoracic wall.  The vital capacity （VC） correlation coefcient was 0.674.  
Further, the risk of pneumonia was high in patients with 13% less than 
the minimum IS volume/preoperative VC ratio and 22% with less than the 
average IS volume/preoperative VC ratio.  Multivariate regression models for 
pneumonia showed the same results regarding the IS volume/VC ratio.  The 
results indicated that IS volumes could be used to predict the incidence of 
complications after VATS-E, and thereby facilitate early application of interven-
tions to prevent pulmonary complications.
Key words : esophageal cancer, postoperative pulmonary complications, incen-
tive spirometry, VATS-E
Introduction
　Transthoracic subtotal esophagectomy used for the treatment of esophageal cancer is 
a highly invasive procedure that is associated with high mortality and morbidity rates 1，2）. 
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Complications from this procedure can drastically reduce patient survival 3）.  In addition, 
open esophagectomy has a higher risk of pulmonary complications than abdominal surgeries. 
Several new surgical devices, perioperative management techniques, and minimally invasive 
procedures have been developed for esophagectomy 3）.  In particular, the newly developed 
minimally invasive surgeries may reduce postoperative complications and have other benets 
such as lower blood loss, a shorter hospital stay, and preservation of respiratory muscles ; 
however, these techniques require additional application and validation 4，5）.
　Since 1996, we have trialed minimally invasive video-assisted thoracoscopic and laparoscop-
ic surgery for esophagectomy （VATS-E）.  VATS-E includes lymphadenectomy for esopha-
geal cancer.  This method has produced fewer complications, but postoperative pulmonary 
complications remain unavoidable.  Postoperatively, patients undergo physiotherapy to reverse 
atelectasis and secretion retention and this may include deep breathing exercises, positioning, 
airway clearance techniques, and mobilization6）.
　Incentive spirometry （IS） is one of the most popular methods for lung expansion in the 
postoperative period.  IS involves deep breathing through a device that provides visual feed-
back with the aim of promoting sustained maximal inspiratory efforts toward enhancing the 
total lung capacity 7）.  IS is thought to maximize both the accuracy of breathing techniques 
and patient motivation 7）.  It was found to be effective in reducing postoperative complica-
tions after upper abdominal surgery 8，9）.  However, the benets of IS during the postopera-
tive recovery period may not be realized in patients undergoing esophagectomy because of 
poor compliance, residual pain, and the general feeling of debility.
　Many different incentive spirometers are available, categorized as either flow type or 
volume type.  Both are important for physiological lung re-expansion and therefore ideal 
for postoperative use 10）.  Volume-oriented IS devices, such as Coach 2TM （Fig. 1）, appear 
to improve diaphragmatic activity and decrease the effort of breathing to a greater extent 
than ow-orientated devices 6）.  Volume-oriented devices may thus be more suitable for the 
postoperative period due to the associated lower levels of breathing effort, pain, fatigue, 
and increased patient incentive to achieve their best potential spirometry volume with these 
devices 11）.
　In our department, the pre- and postoperative IS volumes of all patients undergoing 
VATS-E are recorded, specically the volume inspired on the third attempt in each cycle of 
IS.  In this study, we investigated the relationship between postoperative pulmonary compli-
cations for VATS-E and the perioperative change in IS volumes, with the hypothesis that 
complications can be predicted on the basis of such volume changes.
Patients and Methods
Patients
　This study included 63 patients who underwent VATS-E for thoracic esophageal cancer 
at the Department of Gastroenterological and General Surgery, Showa University, from 
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June 2008 to December 2009.  The median patient age was 64.14 years （range, 41～81 
years）, and there were 48 men and 15 women.  The pre- and postoperative IS volumes 
were recorded for all patients.  Those who did not have both the pre- and postoperative 
IS volumes recorded were excluded.  The World Health Organization （WHO） performance 
status in all cases was either 0 or 1.  Histologically, the main lesion was diagnosed as 
squamous cell carcinoma in 61 cases, and small cell carcinoma in 2 cases.  All patients 
received thoracic epidural analgesia, and all but 7 were extubated at the end of the surgery 
（1～3 days）.  While 25 patients （39.7%） directly underwent surgery, 29 （46.0%） received 
preoperative chemoradiotherapy, and 9 （14.3%） underwent preoperative chemotherapy alone. 
Surgery was performed 4～8 weeks after neoadjuvant treatment.  Preoperative chemoradio-
therapy and staging of the tumor did not inuence the choice of technique.
　All patients underwent detailed preoperative cardiopulmonary risk assessment based on 
their medical history, chest X-ray and electrocardiogram （ECG）, the left ventricular ejection 
fraction （EF） of echocardiography, and pulmonary function assessed by spirometry, includ-
ing vital capacity （VC） and forced expiratory volume at 1 second （FEV1.0%）.  Forty-nine 
patients underwent spirometry postoperatively.
Recording of IS volumes
　The IS volumes of all patients were recorded at our department before and after the 
operation.  During the preoperative visit, patients were educated on the proper technique 
of using the IS device and were instructed to use it for breathing at least 3 times every 
day.  They were requested to record the volume inspired on the third attempt in each cycle 
of using the spirometer.  The average and minimum IS volumes for each day were also 
Fig. 1.  Incentive Spirometry Device Coach 2TM
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recorded.
　The perioperative IS volumes were computed using the pre- and postoperative data.  The 
preoperative volume was the average of IS volumes recorded from admission until the 
operation.  The postoperative scores were computed from day 1 to day 7 after the opera-
tion, and then the average volume, minimum volume, and decrease in IS volume compared 
with the preoperative value were determined.  The average and minimum volumes were 
correlated with the VC determined during preoperative spirometry.
Comparison
　Postoperative pulmonary complications were categorized as pneumonia and atelectasis. 
Pneumonia was diagnosed clinically and radiologically.  Clinical ndings included dyspnea, 
cough, infective sputum, abnormal lung sound, fever （＞ 38℃）, and an increase in the 
number of circulating leucocytes （10,000/mm3）.  The radiological ndings included consolida-
tion on X-ray scans.  Pneumonia was diagnosed for cases in which sputum was aspirated by 
bronchoscopy and/or mini-tracheotomy.  Atelectasis was diagnosed in cases showing positive 
radiological ndings only.
　We examined whether postoperative pulmonary complications are correlated with periop-
erative IS volumes and clinicopathological factors, with the latter divided into pre- and intra-
operative factors.  Preoperative factors considered were age, sex, body mass index, history 
of smoking, alcohol consumption, diabetes mellitus （DM）, chemoradiation therapy, albumin 
level, clinical stage, spirometric data, and echocardiographic data.  The spirometry data col-
lected were VC, %VC, and FEV1.0%.  Postoperative factors considered were operating time, 
intrathoracic operating time, bleeding, intrathoracic bleeding, and adhesion of the lung and 
thoracic wall.  The preoperative comorbidities and clinicopathological data in this cohort of 
patients are summarized in Table 1.
Treatment Procedures
　The standard therapies in our department for thoracic esophageal cancer employ the 
video-assisted thoracoscopic approach, hand-assisted laparoscopic approach, and cervical 
anastomosis.  In all patients in the current study, the esophageal cancers were located in the 
left lateral decubitus.  Five ports were introduced into the right pleural cavity, and a radical 
esophagectomy and mediastinal lymphadenectomy were carried out under thoracoscopic 
guidance.  An esophageal substitute was reconstructed from a gastric tube made using hand-
assisted laparoscopy and inserted via the retrosternal route 12，13）.  Three patients underwent 
reconstruction using a pulled-up ileocecal valve.  Further, 29 patients with locally advanced 
cancer underwent preoperative chemoradiotherapy, involving 35 ～ 42 Gy of radiation with 
chemotherapy comprising cisplatin/nedaplatin and 5-uorouracil.  Three patients underwent 
denitive chemoradiotherapy, involving＞ 50 Gy of radiation and cisplatin plus 5-uorouracil.
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Statistical analysis
　The perioperative IS volumes and clinicopathological factors were correlated with postop-
erative pneumonia and atelectasis.
　The chi-square test was used to compare the IS volumes and the clinicopathological 
factors between the groups, while the Mann-Whitney U-test was used to compare surgical 
outcomes.  Multivariate analysis was performed using a logistic regression.  P ＜ 0.05 was 
considered statistically signicant.  Data were analyzed using the StatView software package 
（Abacus Concepts, Berkeley, CA, USA）.  Signicant differences in the distribution frequen-
cies of the data in Tables 1～ 3, except for age, were determined using Fisher’s exact test. 
The Mann-Whitney U-test was applied to identify differences in age, operative time, and 
blood loss and to compare the values of these parameters between the groups.
Results
　Of the total of 63 patients, postoperatively 22 （37.5%） had some form of pulmonary com-
plication : 9 （14.5%） had pneumonia, while 13 （22.2%） had atelectasis.  Of the postopera-
tive pneumonia cases, 7 were bronchial pneumonia, and 2 were a change for the worse in 
radiation pneumonitis.  The mean time of diagnosis for all complications was 5.67 days after 
operation （range, 2～12 days）.
　Univariate analysis showed an increased risk of atelectasis in patients who had DM, but 
no risk of pneumonia in patients with any of the considered preoperative factors （Table 2）. 
Table 1.  Clinicopathological ndings
Preoperative factors Intraoperative factors
Age
Sex
BMI
Smoking history
Alcohol history
Diabetes
Albumin （g/dl）
Preoperative chemoradiation therapy
aClinical stage
Inspiratory function
VC
%VC
FEV1.0%
Cardiography : EF ratio （%）
Operating time （min）
Intrathoracic operating time （min）
Bleeding （g）
Intrathoracic bleeding （g）
Adhesion
C-stage : clinical stage of Japanese Classification of Esophageal Cancer 10th 
edition
VC : Vital capacity
FEV1.0% : Forced expiratory volume at 1 second
EF ratio : Left ventricular ejection fraction
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In contrast, univariate analysis showed an increased risk of pneumonia in patients who had 
a longer operating time and intrathoracic operating time and adhesion of the lung to the 
thoracic wall.  However, the risk of atelectasis was not associated with intraoperative factors 
in any patient （Table 3）.
　The correlation coefcient of VC was signicant at 0.674, but that of %VC and FEV1.0% 
were not （r＝ 0.117 ［p＞ 0.05］ and 0.07 ［p＞ 0.05］, respectively）.  In a proportion of IS 
volume, the correlation coefcients of VC and %VC were signicant at 0.525 and 0.432 （p
Table 2.  Preoperative clinicopathological factors associated with postoperative pulmonary complications
Clinical factors Postoperative pneumonia Postoperative atelectasis
Yes
（n＝ 9）
No
（n＝ 54） P value
Yes
（n＝ 14）
No
（n＝ 39） P value
Age （y） 65.2 64.1 N.S. 66.0 63.8 N.S.
Body mass index 21.4 21.0 N.S. 20.6 21.2 N.S.
Serum albumin （g/dl）  3.9  4.0 N.S.  3.9  4.0 N.S.
Sex （male/female） 8/1 40/14 N.S.  9/5 39/10 N.S.
Smoking （yes/no） 9/0 51/3 N.S. 13/1 47/2 N.S.
Diabetes （yes/no） 0/9  4/5 N.S. 4/10 0/39 ＜ 0.01
Pre-CRT （yes/no） 6/3 23/31 N.S.  8/6 21/28 N.S.
C-stage （0-I/II-IVa） 6/3 33/21 N.S.  9/5 30/19 N.S.
%VC （%） 109.6 112.1 N.S. 112.3 111.6 N.S.
FEV1.0% 71.8 76.3 N.S. 74.8 76.0 N.S.
EF （%） 65.0 65.3 N.S. 66.6 64.9 N.S.
C-stage : clinical stage of Japanese Classification of Esophageal Cancer 10th edition
Pre-CRT : Preoperative chemoradiation therapy
%VC : Percentage of vital capacity
FEV1.0% : Forced expiratory volume at 1 second
EF:  Left ventricular ejection fraction
Table 3.  Postoperative clinicopathological factors associated with postoperative pulmonary complications
Clinical factors Postoperative pneumonia Postoperative atelectasis
Yes
（n＝ 9）
No
（n＝ 54） P value
Yes
（n＝ 14）
No
（n＝ 39） P value
Operating time （min） 
　400 ≦ /400＞
461.7
8/1
370.3
19/35
＜ 0.01
＜ 0.01
366.4
4/10
388.2
23/26
N.S.
Intrathoracic operating time （min）
　210 ≦ /210＞
260.7
8/1
220.2
25/29
N.S.
＜ 0.05
222.9
7/7
226.9
26/23
N.S.
Bleeding （g）
　300 ≦ /300＞
716.1
5/4
257.9
19/35
N.S.
292.1
5/9
332.3
19/30
N.S.
Intrathoracic bleeding （g）
　200 ≦ /200＞
563.9
4/5
151.2
19/35
N.S.
157.1
6/8
225.3
17/32
N.S.
Adhesion （yes/no） 5/4  8/46 ＜ 0.05 2/12 11/38 N.S.
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＜ 0.01）, respectively, but the FEV1.0% was not （r＝ 0.249 ［p＞ 0.05］） （Table 4）.
　Next, we examined the correlation between postoperative complications and the IS 
volumes.  The average, minimum, and decrease in IS volume were not correlated with post-
operative pneumonia, but the average and decrease were correlated with atelectasis （Table 
5）.
　Neither the average nor minimum IS volume/preoperative VC ratio was found to be a 
risk factor for atelectasis.  However, patients with 13% less than the minimum ratio and 
22% less than the average ratio were found to be at a higher risk for pneumonia （p＜
0.05）.  The results of the correlation of spirometric data and IS volumes are shown in Table 
6, and those of the multivariate regression models for pneumonia are shown in Tables 7 and 
8.
Table 4.  Correlation coefficients of VC, %VC, and FEV1.0% for IS volumes
Relationship （r） VC ％VC FEV1.0%
Average preoperative IS volume （n＝ 63） 0.674＊＊ 0.117 0.07
Rate of decrease in IS volume （n＝ 49） 0.525＊＊  0.432＊ 0.249
VC : Vital capacity
FEV1.0% : Forced expiratory volume at 1 second
＊ p＜ 0.05
＊＊ p＜ 0.01
Table 6.  Ratio of IS volume/preoperative VC for postoperative pneumonia
Yes （n＝ 9） No （n＝ 54）
Minimum IS volume/preoperative VC ≤ 13% 6 （66.7%） 15 （27.8%）
Average IS volume/preoperative VC ≤ 22% 6 （66.7%） 13 （24.1%）
VC : Vital capacity
IS : Incentive spirometry
Table 5.  Correlation between IS volumes and postoperative pulmonary
IS volume Postoperative pneumonia Postoperative atelectasis
Yes
（n＝ 9）
No
（n＝ 54） P-value
Yes
（n＝ 14）
No
（n＝ 39） P value
Average 848.41 ± 431.35 1009.15 ± 427.35 N.S. 768.01 ± 282.61 1050.20 ± 444.86 ＜ 0.05
Reduction rate 0.44 ± 0.13  0.55 ± 0.26 N.S. 0.44 ± 0.130 0.56 ± 0.26 ＜ 0.05
Minimum 527.78 ± 363.24 657.78 ± 349.74 N.S. 491.07 ± 179.91 681.53 ± 377.86 N.S.
complications
IS : Incentive spirometry
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Discussion
　Despite improvements in the surgical techniques and perioperative management of 
esophageal surgery, the morbidity and mortality rates remain high in comparison to other 
procedures 14，15）.  Reported perioperative morbidity and mortality rates of up to 60% and 
14%, respectively, have been associated with esophagectomy for esophageal cancer 16）.  In 
recent years, several techniques have been recommended to prevent pulmonary complications 
after esophagectomy, such as thoracic epidural analgesia, patient-controlled epidural analgesia, 
smoking cessation, preoperative respiratory rehabilitation, postoperative early rehabilitation, 
oral care, steroid administration, neutrophil elastase inhibitor administration, and minimally 
invasive surgical procedures3，17）.  However, the only factor found to be an independent pre-
dictor of reduced postoperative respiratory failure is minimally invasive surgery 18-20）.  Patients 
undergoing minimally invasive esophagectomy showed less surgical access-related trauma 
and possibly less impairment of respiratory function in the postoperative period, and such 
procedural changes are associated with lower pulmonary complication rates.  Less restrictive 
pulmonary damage was also reported following thoracoscopic surgery compared to open 
surgery, because thoracoscopic surgery can reduce pulmonary damage caused by chest wall 
Table 7.  Logistic regression analysis for postoperative pneumonia and minimum IS volume
SD P value OR 95% CI
Minimum IS volume/VC ≤ 13% 0.950 0.0265  8.23 1.28-52.98
Adhesion 0.987 0.0832  5.58 0.80-38.25
Operating time 1.181 0.0364 11.84 1.17-119.90
SD : standard deviation
OR : Odds ratio
CI : Confidence interval
VC : Vital capacity
IS : Incentive spirometry
Table 8.  Logistic regression analysis for postoperative pneumonia and average IS volume
SD P value OR 95% CI
Average IS volume/VC ≤ 22% 1.041 0.0104 14.40 1.87-110.76
Adhesion 1.044 0.1614  4.36 0.58-33.41
Operating time 1.290 0.0218 19.30 1.54-242.16
SD : standard deviation
OR : Odds ratio
CI : Confidence interval
VC : Vital capacity
IS : Incentive spirometry
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injury 21）.  Murai et al 22） reported that VATS-E is less invasive and safer than esophagec-
tomy via open thoracotomy with respect to postoperative quality of life and perioperative 
care.
　As perioperative management in the present study, we used minimally invasive surgery, 
epidural analgesia, steroids, smoking cessation at least 1 month before the surgery, and 
respiratory rehabilitation using IS before and after the operation.  Extubation was performed 
on the day of surgery, and from 1 postoperative day onward, the patients underwent reha-
bilitation including walking, IS, and oral intake of water.  In general, if patients experience 
difculty in expectoration, suction by bronchoscopy is conducted 23）.  However, patients who 
underwent VATS-E at our department rst underwent rehabilitation including walking and 
IS, and at our department, suction is not conducted using bronchial ber, thin tracheal intu-
bation.  Patients who required suction in such a manner were diagnosed with pneumonia in 
this study.
　Recent studies have identied several factors that contribute to the decreased incidence 
of pulmonary complications after esophagectomy.  Risk factors for perioperative pulmonary 
complications include obstructive pulmonary injury, clinical stage, age, neoadjuvant chemoradi-
ation therapy, and bleeding during the surgery 24）.  In particular, some studies have reported 
preoperative respiratory functions as risk factors.  Fan et al 25） reported a good correlation 
between the incidence of complications and the preoperative peak expiratory ow rate when 
it was less than 65% of the predicted normal value.  Further, Nagawa et al 26） reported 
accurate assessments of the risk of postoperative pulmonary complications by calculating a 
risk score based on VC, liver cirrhosis, and tumor stage, while Avendano et al 27） found that 
patients with FEV1.0%＜ 65% of the predicted value are at risk for pulmonary complica-
tions after esophagectomy.
　The purpose of the present study was to identify factors that predict pulmonary complica-
tions after VATS-E, with the aim of instituting preventive interventions at an early stage. 
All patients who underwent VATS-E in this study also underwent rehabilitation using IS. 
We therefore investigated whether pulmonary complications after VATS-E are correlated 
with perioperative changes in the IS volumes and whether complications can predicted on 
the basis of changes in the IS volumes.
　In this study, 13 of the 63 patients had atelectasis, and the factors correlated to this post-
operative complication were found to be the average IS volume and a decrease in the IS 
volume.  The atelectasis improved with rehabilitation that included walking and IS.  There-
fore, we do not believe that atelectasis has an important clinical inuence.  However, we 
were unable to predict pulmonary complications from IS volumes alone.  A reason for this 
could be that the maximum volume of IS using the Coach 2TM in adult patients is usually 
a maximum volume of 2500 ml and 4000 ml.  In the present study, it was 2500 ml, and in 
15 patients, the preoperative average IS volume was 2500 ml.  Thus, it is likely that in some 
of these patients, the volume exceeded 2500 ml.  Each score of the average IS volume, 
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decrease in IS volume, and minimum IS volume was not correlated with postoperative pneu-
monia, while the correlation coefcient of VC was 0.674 （P＜ 0.01）.  We thus proposed that 
the ratio of the IS volume to VC could be used as a predictive factor, because this ratio 
indicates intraoperative respiratory function and considers differences among patients.  Using 
this ratio, we then showed that the risk of postoperative pneumonia was high in patients 
with 13% less than the minimum ratio and 22% less than the average ratio.  Future investi-
gation will now focus on the change in IS volume using the 4000 ml device because of the 
consideration of patient differences.
　This study precluded patients who had pulmonary dysfunction, since those with severe 
respiratory dysfunction and pneumonia up to 1 month before the operation and those who 
had smoked for at least 1 month before the surgery were not eligible to undergo VATS-
E.  Since the risk of postoperative respiratory complications was high for these patients, 
we treated them using the mediastinoscopic approach or salvage surgery by VATS-E.  This 
could be another reason why we were not able to predict pulmonary complications from 
the IS volumes alone.
　In conclusion, using IS we identied factors predictive of pneumonia after VATS-E.  We 
believe that future studies could enable prediction of pulmonary complications by early 
using the IS volume.
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